Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.90 | N/A |
| PEG Ratio (TTM) | 0.50 | N/A |
| P/S Ratio (TTM) | 0.83 | N/A |
| P/B Ratio (TTM) | 1.80 | N/A |
| P/FCF Ratio (TTM) | 16.73 | N/A |
| Price to 5YR AVG Earnings Ratio | 47.28 | N/A |
| Price to 5YR AVG FCF Ratio | -25,600.24 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.98% | N/A |
| ROE (TTM) | 7.29% | N/A |
| Net Profit Margin (TTM) | 3.13% | N/A |
| ROIC 5YR AVG | 7.22% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 78.13% | -60.09% | 264.96% |
| Revenue | 8.40% | 6.11% | 7.79% |
| Net Income | 80.18% | -60.55% | 264.21% |
| Cash Flow | 250.31% | -26.79% | 24.49% |
Health (60%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.87 | N/A |
| Quick Ratio (TTM) | 1.26 | N/A |
| D/E Ratio (TTM) | 0.02 | N/A |
| Interest Coverage (TTM) | 5.26 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.23 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 0.18% | N/A |